Stay updated with breaking news from Hepatol Comms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LIVMARLI First and Only Treatment Approved in Mainland China for Cholestatic Pruritus in ALGS CANbridge to Hold Investor CallBEIJING & BURLINGTON, Mass. ...
CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone - read this article along with other careers information, tips and advice on BioSpace
CORRECTING and REPLACING CANbridge Announces Approval of CAN108 for Rare Liver Disease, Alagille Syndrome, Under the Early and Pilot Implementation Policy in Boao Lecheng International Medical Tourism Pilot Zone - read this article along with other careers information, tips and advice on BioSpace